Published in J Virol on November 01, 2004
Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev (2011) 2.22
Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog (2007) 1.97
The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog (2009) 1.86
Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A (2006) 1.70
X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J Virol (2007) 1.45
Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer (2012) 1.38
Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42. J Virol (2006) 1.38
Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells. J Virol (2005) 1.34
Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol (2009) 1.31
Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol (2007) 1.31
Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest (2005) 1.26
Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage. BMC Pediatr (2012) 1.21
Extracellular vesicles and their convergence with viral pathways. Adv Virol (2012) 1.18
Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells. J Virol (2006) 1.14
Efficient replication of Epstein-Barr virus in stratified epithelium in vitro. Proc Natl Acad Sci U S A (2014) 1.12
Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol (2005) 1.12
Epstein-Barr virus transcytosis through polarized oral epithelial cells. J Virol (2013) 1.01
Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells. J Oral Pathol Med (2008) 1.00
A virtual look at Epstein-Barr virus infection: simulation mechanism. J Theor Biol (2008) 0.97
Epstein-Barr virus latent genes. Exp Mol Med (2015) 0.96
Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Herpesviridae (2011) 0.95
The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells. J Virol (2006) 0.93
Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes. J Virol (2014) 0.93
Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma. Ther Clin Risk Manag (2014) 0.92
EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells. Virology (2009) 0.90
A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog (2007) 0.90
Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection. Immunology (2009) 0.87
Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression. J Virol (2014) 0.87
Compatibility of the gH homologues of Epstein-Barr virus and related lymphocryptoviruses. J Gen Virol (2007) 0.84
EBV infection is common in gingival epithelial cells of the periodontium and worsens during chronic periodontitis. PLoS One (2013) 0.83
EBV Persistence-Introducing the Virus. Curr Top Microbiol Immunol (2015) 0.82
Oropharyngeal shedding of Epstein-Barr virus in the absence of circulating B cells. J Infect Dis (2008) 0.81
Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals. J Theor Biol (2012) 0.79
Telomerase activity impacts on Epstein-Barr virus infection of AGS cells. PLoS One (2015) 0.78
Epstein-Barr Virus: Diseases Linked to Infection and Transformation. Front Microbiol (2016) 0.78
Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Int J Cancer (2016) 0.77
Replication of Epstein-Barr virus primary infection in human tonsil tissue explants. PLoS One (2011) 0.75
Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell (1975) 15.93
Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell (1993) 5.86
Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med (2004) 5.61
Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol (2001) 5.08
Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med (1985) 4.78
Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med (1984) 4.47
EBV persistence in memory B cells in vivo. Immunity (1998) 4.44
Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med (2002) 4.33
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol (1994) 4.08
The biology of the 17-1A antigen (Ep-CAM). J Mol Med (Berl) (1999) 3.94
Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol (2002) 3.52
The transmission of infectious mononucleosis. Am J Med Sci (1955) 3.32
A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell (1995) 3.17
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity (2000) 2.96
Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature (1984) 2.81
Epstein-Barr virus infection and replication in a human epithelial cell system. Nature (1992) 2.62
Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol (1998) 2.61
Stratification and terminal differentiation of cultured epidermal cells. Nature (1982) 2.44
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A (2003) 2.31
Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science (1999) 2.21
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med (2003) 2.21
Immunology of the tonsils. Immunol Today (1998) 2.10
Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J Pathol (1997) 1.72
Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int J Cancer (1977) 1.58
The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity (2002) 1.56
fyn tyrosine kinase is involved in keratinocyte differentiation control. Genes Dev (1995) 1.51
Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol (1999) 1.41
CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J Virol (1999) 1.39
Entry of viruses through the epithelial barrier: pathogenic trickery. Nat Rev Mol Cell Biol (2003) 1.36
Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol (2004) 1.36
Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. J Gen Virol (1999) 1.27
Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections. J Virol (2000) 1.27
Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet (1988) 1.25
The Epstein-Barr virus as a model of virus-host interactions. Br Med Bull (1985) 1.24
Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol (1999) 1.23
Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals. Blood (1997) 1.23
Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am J Pathol (1997) 1.22
Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol (1997) 1.20
Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells. Mol Pathol (2000) 1.19
Epstein-Barr virus: inhibition of replication by three new drugs. Science (1983) 1.17
Three distinct keratinocyte subtypes identified in human oral epithelium by their patterns of keratin expression in culture and in xenografts. Differentiation (1990) 1.16
Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. J Infect Dis (2001) 1.16
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15
The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat (1994) 1.14
Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol (1999) 1.09
Expression and function of the keratinocyte integrins. Dev Suppl (1993) 1.04
Infection of breast epithelial cells with Epstein-Barr virus via cell-to-cell contact. J Natl Cancer Inst (2000) 1.04
Epstein-Barr virus and epithelial cells: a possible role for the virus in the development of cervical carcinoma. Cancer Surv (1988) 1.02
A limited role for retinoic acid and retinoic acid receptors RAR alpha and RAR beta in regulating keratin 19 expression and keratinization in oral and epidermal keratinocytes. J Invest Dermatol (1996) 1.02
Attempt to infect nonmalignant nasopharyngeal epithelial cells from humans and squirrel monkeys with Epstein-Barr virus. J Natl Cancer Inst (1980) 1.01
Infection of normal human epithelial cells by Epstein-Barr virus. Science (1983) 0.96
Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J Virol (2003) 0.95
Epstein-Barr virus in epithelium. Nature (1984) 0.90
Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases. Am J Surg Pathol (1996) 0.87
Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation. Transplant Proc (1989) 0.86
Differential cytokeratin and glycoconjugate expression by the surface and crypt epithelia of human palatine tonsils. Histochem Cell Biol (2000) 0.81
Keratins as molecular markers of epithelial differentiation: differential expression in crypt epithelium of human palatine tonsils. Ann Otol Rhinol Laryngol (1991) 0.78
Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A (2010) 6.72
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol (2005) 3.16
EBV and systemic lupus erythematosus: a new perspective. J Immunol (2005) 2.34
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A (2003) 2.31
The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog (2009) 1.86
Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol (2008) 1.85
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A (2007) 1.82
The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity (2002) 1.56
The intersection of Epstein-Barr virus with the germinal center. J Virol (2009) 1.37
Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol (2004) 1.36
On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood (2007) 1.36
Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc Natl Acad Sci U S A (2005) 1.34
Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol (2007) 1.31
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer (2006) 1.26
A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog (2011) 1.26
Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol (2005) 1.23
Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J Gen Virol (2003) 1.16
Influence of EBV on the peripheral blood memory B cell compartment. J Immunol (2007) 1.12
Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol (2005) 1.12
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest (2012) 1.12
Epstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350. J Virol (2005) 1.05
Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol (2009) 1.04
Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes. J Immunol (2010) 1.00
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology (2010) 0.98
Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. J Med Virol (2010) 0.96
In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin. J Virol (2005) 0.94
Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol (2012) 0.93
EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. Virol J (2005) 0.92
Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol (2011) 0.92
A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog (2007) 0.90
Epstein-Barr virus replication in tongue epithelial cells. J Gen Virol (2002) 0.89
Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res (2008) 0.89
Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics. J Med Virol (2014) 0.87
Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay. J Clin Microbiol (2003) 0.86
Chemotaxis in densely populated tissue determines germinal center anatomy and cell motility: a new paradigm for the development of complex tissues. PLoS One (2011) 0.86
Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivo. Methods Mol Biol (2005) 0.85
An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis. Genes Cancer (2011) 0.83
Analysis of viral microRNA exchange via exosomes in vitro and in vivo. Methods Mol Biol (2013) 0.82
Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome. Mod Pathol (2005) 0.82
Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30. Infect Agent Cancer (2010) 0.81
The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation. PLoS Pathog (2013) 0.79
Pathogens cooperate in lymphomagenesis. Nat Med (2007) 0.78
Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma. J Med Virol (2012) 0.78
Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease. J Med Virol (2003) 0.75
IFN-alpha-stimulated genes and Epstein-Barr virus gene expression distinguish WHO type II and III nasopharyngeal carcinomas. Cancer Res (2007) 0.75